EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Multiple low dose streptozotocin‐induced diabetes as a model for studying autoimmune diabetes in humans

Ivan Koprivica, Suzana Stanisavljević, Dragica Mićanović, Ivana Stojanović, Đorđe Miljković iD

Animal Models and Experimental Medicine · 2025-09 · 8 (9) · 1539-1551

DOI: 10.1002/ame2.70050 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 24.06.2025. Verfasst von Ivan Koprivica und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute for Biological Research "Siniša Stanković" - National Institute of Republic of Serbia, University of Belgrade, Be…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Experimental, Disease Models, Animal, Streptozocin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science, Technological Development, and Innovation, Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The autoimmune response directed against pancreatic β cells is the most essential pathogenic process in type 1 diabetes (T1D) in humans. Spontaneous animal models of T1D greatly contribute to our understanding of the disease pathogenesis and therapeutic options. Amongst many disease models, a significant proportion of T1D research is performed on multiple low dose streptozotocin induced diabetes in experimental animals, in parallel. Here, we discuss advantages of this model for contemporary T1D research. Additionally, challenges and perspectives for further improvement of the model are presented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Diabetes Mellitus, ExperimentalDisease Models, AnimalStreptozocinAnimalsHumansMiceInsulin-Secreting Cells

Stichwörter der Autor:innen

animal modelautoimmunitystreptozotocintype 1 diabetes

Substanzen

Streptozocin

Autor:innen und Institutionen

  • Department of Immunology, Institute for Biological Research "Siniša Stanković" - National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.

ORCID-Profile: Đorđe Miljković

Förderung

  • Ministry of Science, Technological Development, and Innovation, Republic of Serbia

Zitieren

APA

Koprivica, I., Stanisavljević, S., Mićanović, D., Stojanović, I., & Miljković, Đ. (2025). Multiple low dose streptozotocin‐induced diabetes as a model for studying autoimmune diabetes in humans. Animal Models and Experimental Medicine, 8(9), 1539-1551. https://doi.org/10.1002/ame2.70050

Vancouver

Koprivica I, Stanisavljević S, Mićanović D, Stojanović I, Miljković Đ. Multiple low dose streptozotocin‐induced diabetes as a model for studying autoimmune diabetes in humans. Animal Models and Experimental Medicine. 2025;8(9):1539-1551. doi:10.1002/ame2.70050

BibTeX
@article{Koprivica2025,
  author = {Koprivica, Ivan and Stanisavljević, Suzana and Mićanović, Dragica and Stojanović, Ivana and Miljković, Đorđe},
  title = {Multiple low dose streptozotocin‐induced diabetes as a model for studying autoimmune diabetes in humans},
  journal = {Animal Models and Experimental Medicine},
  year = {2025},
  volume = {8},
  number = {9},
  pages = {1539--1551},
  doi = {10.1002/ame2.70050}
}
Kostenlos starten →